Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 26 entries
Sorted by: Best Match Show Resources per page
The environment as a significant cofactor for multiply resistant nosocomial infections.

Seminars in respiratory infections

Cua A, Lutwick LI.
PMID: 12226804
Semin Respir Infect. 2002 Sep;17(3):246-9. doi: 10.1053/srin.2002.35541.

The role of antimicrobial agent control in the war against the development of resistance is not the only issue in this conflict. In this article, the role the environment plays in the spread of pathogens is discussed.

Cite
Cua A, Lutwick LI. The environment as a significant cofactor for multiply resistant nosocomial infections. Semin Respir Infect. 2002;17(3):246-9doi: 10.1053/srin.2002.35541.
Cua, A., & Lutwick, L. I. (2002). The environment as a significant cofactor for multiply resistant nosocomial infections. Seminars in respiratory infections, 17(3), 246-9. https://doi.org/10.1053/srin.2002.35541
Cua, Arnold, and Lutwick, Larry I. "The environment as a significant cofactor for multiply resistant nosocomial infections." Seminars in respiratory infections vol. 17,3 (2002): 246-9. doi: https://doi.org/10.1053/srin.2002.35541
Cua A, Lutwick LI. The environment as a significant cofactor for multiply resistant nosocomial infections. Semin Respir Infect. 2002 Sep;17(3):246-9. doi: 10.1053/srin.2002.35541. PMID: 12226804.
Copy Download .nbib Format: NLM
[Ventilator-associated pneumonia caused by multi-drug resistant Acinetobacter baumannii infection in a extremely low birth weight infant].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics

Han TY, Piao MH, Ge YN.
PMID: 22809616
Zhongguo Dang Dai Er Ke Za Zhi. 2012 Jul;14(7):560-1.

No abstract available.

Cite
Han TY, Piao MH, Ge YN. [Ventilator-associated pneumonia caused by multi-drug resistant Acinetobacter baumannii infection in a extremely low birth weight infant]. Zhongguo Dang Dai Er Ke Za Zhi. 2012;14(7):560-1
Han, T. Y., Piao, M. H., & Ge, Y. N. (2012). [Ventilator-associated pneumonia caused by multi-drug resistant Acinetobacter baumannii infection in a extremely low birth weight infant]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 14(7), 560-1.
Han, Tong-Yan, et al. "[Ventilator-associated pneumonia caused by multi-drug resistant Acinetobacter baumannii infection in a extremely low birth weight infant]." Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics vol. 14,7 (2012): 560-1.
Han TY, Piao MH, Ge YN. [Ventilator-associated pneumonia caused by multi-drug resistant Acinetobacter baumannii infection in a extremely low birth weight infant]. Zhongguo Dang Dai Er Ke Za Zhi. 2012 Jul;14(7):560-1. Chinese. PMID: 22809616.
Copy Download .nbib Format: NLM
The Dutch questionnaire-based risk assessment upon hospital admission is unable to identify the majority of carriers of multi-drug-resistant micro-organisms.

The Journal of hospital infection

Vainio S, Bril W.
PMID: 34246722
J Hosp Infect. 2021 Sep;115:124-125. doi: 10.1016/j.jhin.2021.07.001. Epub 2021 Jul 08.

No abstract available.

Cite
Vainio S, Bril W. The Dutch questionnaire-based risk assessment upon hospital admission is unable to identify the majority of carriers of multi-drug-resistant micro-organisms. J Hosp Infect. 2021;115:124-125doi: 10.1016/j.jhin.2021.07.001.
Vainio, S., & Bril, W. (2021). The Dutch questionnaire-based risk assessment upon hospital admission is unable to identify the majority of carriers of multi-drug-resistant micro-organisms. The Journal of hospital infection, 115124-125. https://doi.org/10.1016/j.jhin.2021.07.001
Vainio, S, and Bril, W. "The Dutch questionnaire-based risk assessment upon hospital admission is unable to identify the majority of carriers of multi-drug-resistant micro-organisms." The Journal of hospital infection vol. 115 (2021): 124-125. doi: https://doi.org/10.1016/j.jhin.2021.07.001
Vainio S, Bril W. The Dutch questionnaire-based risk assessment upon hospital admission is unable to identify the majority of carriers of multi-drug-resistant micro-organisms. J Hosp Infect. 2021 Sep;115:124-125. doi: 10.1016/j.jhin.2021.07.001. Epub 2021 Jul 08. PMID: 34246722.
Copy Download .nbib Format: NLM
Outcomes after Surgery among Patients Diagnosed with One or More Multi-Drug-Resistant Organisms.

Surgical infections

Gupta A, Tennakoon L, Spain DA, Forrester JD.
PMID: 33471591
Surg Infect (Larchmt). 2021 Sep;22(7):722-729. doi: 10.1089/sur.2020.400. Epub 2021 Jan 20.

No abstract available.

Cite
Gupta A, Tennakoon L, Spain DA, et al. Outcomes after Surgery among Patients Diagnosed with One or More Multi-Drug-Resistant Organisms. Surg Infect (Larchmt). 2021;22(7):722-729doi: 10.1089/sur.2020.400.
Gupta, A., Tennakoon, L., Spain, D. A., & Forrester, J. D. (2021). Outcomes after Surgery among Patients Diagnosed with One or More Multi-Drug-Resistant Organisms. Surgical infections, 22(7), 722-729. https://doi.org/10.1089/sur.2020.400
Gupta, Anshal, et al. "Outcomes after Surgery among Patients Diagnosed with One or More Multi-Drug-Resistant Organisms." Surgical infections vol. 22,7 (2021): 722-729. doi: https://doi.org/10.1089/sur.2020.400
Gupta A, Tennakoon L, Spain DA, Forrester JD. Outcomes after Surgery among Patients Diagnosed with One or More Multi-Drug-Resistant Organisms. Surg Infect (Larchmt). 2021 Sep;22(7):722-729. doi: 10.1089/sur.2020.400. Epub 2021 Jan 20. PMID: 33471591.
Copy Download .nbib Format: NLM
[Current trend in bacterial acquisition of multiple drug resistance].

Nihon rinsho. Japanese journal of clinical medicine

Yamaguchi K.
PMID: 22413515
Nihon Rinsho. 2012 Feb;70(2):185-6.

No abstract available.

Cite
Yamaguchi K. [Current trend in bacterial acquisition of multiple drug resistance]. Nihon Rinsho. 2012;70(2):185-6
Yamaguchi, K. (2012). [Current trend in bacterial acquisition of multiple drug resistance]. Nihon rinsho. Japanese journal of clinical medicine, 70(2), 185-6.
Yamaguchi, Keizo. "[Current trend in bacterial acquisition of multiple drug resistance]." Nihon rinsho. Japanese journal of clinical medicine vol. 70,2 (2012): 185-6.
Yamaguchi K. [Current trend in bacterial acquisition of multiple drug resistance]. Nihon Rinsho. 2012 Feb;70(2):185-6. Japanese. PMID: 22413515.
Copy Download .nbib Format: NLM
[Phage therapy is back - maybe?].

Medecine sciences : M/S

Jordan B.
PMID: 31625905
Med Sci (Paris). 2019 Oct;35(10):806-809. doi: 10.1051/medsci/2019149. Epub 2019 Oct 18.

Bacteriophages were advocated as therapeutic agents more than a century ago, but the advent of antibiotics relegated them to a very minor role. Today, multi-drug resistant bacteria are a serious health problem, and phage therapy enjoys renewed interest. Recent...

Cite
Jordan B. Cent ans après, le retour de la phagothérapie ? - Chroniques génomiques. [Phage therapy is back - maybe?]. Med Sci (Paris). 2019;35(10):806-809doi: 10.1051/medsci/2019149.
Jordan, B. (2019). Cent ans après, le retour de la phagothérapie ? - Chroniques génomiques. [Phage therapy is back - maybe?]. Medecine sciences : M/S, 35(10), 806-809. https://doi.org/10.1051/medsci/2019149
Jordan, Bertrand. "Cent ans après, le retour de la phagothérapie ? - Chroniques génomiques." [Phage therapy is back - maybe?]. Medecine sciences : M/S vol. 35,10 (2019): 806-809. doi: https://doi.org/10.1051/medsci/2019149
Jordan B. Cent ans après, le retour de la phagothérapie ? - Chroniques génomiques. [Phage therapy is back - maybe?]. Med Sci (Paris). 2019 Oct;35(10):806-809. doi: 10.1051/medsci/2019149. Epub 2019 Oct 18. French. PMID: 31625905.
Copy Download .nbib Format: NLM
Get back to work.

The Medical journal of Australia

Kappagoda A.
PMID: 24484084
Med J Aust. 2014 Feb 03;200(2):63. doi: 10.5694/mja14.c0203.

No abstract available.

Cite
Kappagoda A. Get back to work. Med J Aust. 2014;200(2):63doi: 10.5694/mja14.c0203.
Kappagoda, A. (2014). Get back to work. The Medical journal of Australia, 200(2), 63. https://doi.org/10.5694/mja14.c0203
Kappagoda, Astika. "Get back to work." The Medical journal of Australia vol. 200,2 (2014): 63. doi: https://doi.org/10.5694/mja14.c0203
Kappagoda A. Get back to work. Med J Aust. 2014 Feb 03;200(2):63. doi: 10.5694/mja14.c0203. PMID: 24484084.
Copy Download .nbib Format: NLM
[Superbugs from elsewhere].

Revue medicale suisse

Lew D, Calandra T.
PMID: 21674890
Rev Med Suisse. 2011 Apr 27;7(292):883-4.

No abstract available.

Cite
Lew D, Calandra T. Ces superbactéries qui viennent d'ailleurs. [Superbugs from elsewhere]. Rev Med Suisse. 2011;7(292):883-4
Lew, D., & Calandra, T. (2011). Ces superbactéries qui viennent d'ailleurs. [Superbugs from elsewhere]. Revue medicale suisse, 7(292), 883-4.
Lew, Daniel, and Calandra, Thierry. "Ces superbactéries qui viennent d'ailleurs." [Superbugs from elsewhere]. Revue medicale suisse vol. 7,292 (2011): 883-4.
Lew D, Calandra T. Ces superbactéries qui viennent d'ailleurs. [Superbugs from elsewhere]. Rev Med Suisse. 2011 Apr 27;7(292):883-4. French. PMID: 21674890.
Copy Download .nbib Format: NLM
Efficacy and safety of fecal microbiota transplantation for decolonization of intestinal multidrug-resistant microorganism carriage: beyond .

Annals of medicine

Yoon YK, Suh JW, Kang EJ, Kim JY.
PMID: 31468999
Ann Med. 2019 Nov - Dec;51(7):379-389. doi: 10.1080/07853890.2019.1662477. Epub 2019 Sep 13.

Persistent reservoirs of multidrug-resistant microorganisms (MDRO) that are prevalent in hospital settings and communities can lead to the spread of MDRO. Currently, there are no effective decolonization strategies, especially non-pharmacological strategies without antibiotic regimens. Our aim was to evaluate...

Cite
Yoon YK, Suh JW, Kang EJ, et al. Efficacy and safety of fecal microbiota transplantation for decolonization of intestinal multidrug-resistant microorganism carriage: beyond . Ann Med. 2019;51(7):379-389doi: 10.1080/07853890.2019.1662477.
Yoon, Y. K., Suh, J. W., Kang, E. J., & Kim, J. Y. (2019). Efficacy and safety of fecal microbiota transplantation for decolonization of intestinal multidrug-resistant microorganism carriage: beyond . Annals of medicine, 51(7), 379-389. https://doi.org/10.1080/07853890.2019.1662477
Yoon, Young Kyung, et al. "Efficacy and safety of fecal microbiota transplantation for decolonization of intestinal multidrug-resistant microorganism carriage: beyond ." Annals of medicine vol. 51,7 (2019): 379-389. doi: https://doi.org/10.1080/07853890.2019.1662477
Yoon YK, Suh JW, Kang EJ, Kim JY. Efficacy and safety of fecal microbiota transplantation for decolonization of intestinal multidrug-resistant microorganism carriage: beyond . Ann Med. 2019 Nov - Dec;51(7):379-389. doi: 10.1080/07853890.2019.1662477. Epub 2019 Sep 13. PMID: 31468999; PMCID: PMC7877873.
Copy Download .nbib Format: NLM
[Multiple-drug resistant bacteria: how do they come to exist, spread, and express their pathogenicity?].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

Tateda K, Ishii Y.
PMID: 14679799
Nihon Naika Gakkai Zasshi. 2003 Nov 10;92(11):2097-103.

No abstract available.

Cite
Tateda K, Ishii Y. [Multiple-drug resistant bacteria: how do they come to exist, spread, and express their pathogenicity?]. Nihon Naika Gakkai Zasshi. 2003;92(11):2097-103
Tateda, K., & Ishii, Y. (2003). [Multiple-drug resistant bacteria: how do they come to exist, spread, and express their pathogenicity?]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 92(11), 2097-103.
Tateda, Kazuhiro, and Ishii, Yoshikazu. "[Multiple-drug resistant bacteria: how do they come to exist, spread, and express their pathogenicity?]." Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine vol. 92,11 (2003): 2097-103.
Tateda K, Ishii Y. [Multiple-drug resistant bacteria: how do they come to exist, spread, and express their pathogenicity?]. Nihon Naika Gakkai Zasshi. 2003 Nov 10;92(11):2097-103. Japanese. PMID: 14679799.
Copy Download .nbib Format: NLM
Endorsing Chennai declaration and implementing the strategy.

Indian journal of medical microbiology

Kanungo R.
PMID: 24713893
Indian J Med Microbiol. 2014 Apr-Jun;32(2):109. doi: 10.4103/0255-0857.129762.

No abstract available.

Cite
Kanungo R. Endorsing Chennai declaration and implementing the strategy. Indian J Med Microbiol. 2014;32(2):109doi: 10.4103/0255-0857.129762.
Kanungo, R. (2014). Endorsing Chennai declaration and implementing the strategy. Indian journal of medical microbiology, 32(2), 109. https://doi.org/10.4103/0255-0857.129762
Kanungo, Reba. "Endorsing Chennai declaration and implementing the strategy." Indian journal of medical microbiology vol. 32,2 (2014): 109. doi: https://doi.org/10.4103/0255-0857.129762
Kanungo R. Endorsing Chennai declaration and implementing the strategy. Indian J Med Microbiol. 2014 Apr-Jun;32(2):109. doi: 10.4103/0255-0857.129762. PMID: 24713893.
Copy Download .nbib Format: NLM
Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal .

Global health action

Nkansa-Gyamfi NA, Kazibwe J, Traore DAK, Nji E.
PMID: 32909519
Glob Health Action. 2019 Dec 13;12:1815272. doi: 10.1080/16549716.2020.1815272.

BACKGROUND: The majority of existing studies aimed at investigating the incidence and prevalence of multidrug-resistance by bacteria have been performed in healthcare settings. Relatively few studies have been conducted in community settings, but these have consistently shown a high...

Cite
Nkansa-Gyamfi NA, Kazibwe J, Traore DAK, et al. Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal . Glob Health Action. 2019;12:1815272doi: 10.1080/16549716.2020.1815272.
Nkansa-Gyamfi, N. A., Kazibwe, J., Traore, D. A. K., & Nji, E. (2019). Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal . Global health action, 121815272. https://doi.org/10.1080/16549716.2020.1815272
Nkansa-Gyamfi, Nana Adoma, et al. "Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal ." Global health action vol. 12 (2019): 1815272. doi: https://doi.org/10.1080/16549716.2020.1815272
Nkansa-Gyamfi NA, Kazibwe J, Traore DAK, Nji E. Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal . Glob Health Action. 2019 Dec 13;12:1815272. doi: 10.1080/16549716.2020.1815272. PMID: 32909519; PMCID: PMC7782630.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 26 entries